| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119700 | Journal of Clinical Virology | 2016 | 11 Pages |
Abstract
3-year longitudinal data reinforce evidence from previous studies that RealTime can be safely used in primary HPV-based cervical cancer screening. Concurrent partial genotyping for HPV16/18 should be strongly considered as a triage method for HPV screen-positive women.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mario Poljak, Anja OÅ¡trbenk, Katja Seme, Anja Å terbenc, Nina JanÄar, Eda VrtaÄnik Bokal,